Long term effects of dietary sodium reduction on cardiovascular disease outcomes

Observational follow-up of the trials of hypertension prevention (TOHP)

Nancy R. Cook, Jeffrey A. Cutler, Eva Obarzanek, Julie E. Buring, Kathryn M. Rexrode, Shiriki K. Kumanyika, Lawrence Appel, Paul K. Whelton

Research output: Contribution to journalArticle

Abstract

Objective: To examine the effects of reduction in dietary sodium intake on cardiovascular events using data from two completed randomised trials, TOHP I and TOHP II. Design: Longterm follow-up assessed 10-15 years after the original trial. Setting: 10 clinic sites in 1987-90 (TOHP I) and nine sites in 1990-5 (TOHP II). Central follow-up conducted by post and phone. Participants: Adults aged 30-54 years with prehypertension. Intervention: Dietary sodium reduction, including comprehensive education and counselling on reducing intake, for 18 months (TOHP I) or 36-48 months (TOHP II). Main outcome measure: Cardiovascular disease (myocardial infarction, stroke, coronary revascularisation, or cardiovascular death). Results: 744 participants in TOHP I and 2382 in TOHP II were randomised to a sodium reduction intervention or control. Net sodium reductions in the intervention groups were 44 mmol/24 h and 33 mmol/24 h, respectively. Vital status was obtained for all participants and follow-up information on morbidity was obtained from 2415 (77%), with 200 reporting a cardiovascular event. Risk of a cardiovascular event was 25% lower among those in the intervention group (relative risk 0.75, 95% confidence interval 0.57 to 0.99, P=0.04), adjusted for trial, clinic, age, race, and sex, and 30% lower after further adjustment for baseline sodium excretion and weight (0.70, 0.53 to 0.94), with similar results in each trial. In secondary analyses, 67 participants died (0.80, 0.51 to 1.26, P=0.34). Conclusion: Sodium reduction, previously shown to lower blood pressure, may also reduce long term risk of cardiovascular events.

Original languageEnglish (US)
Pages (from-to)885-888
Number of pages4
JournalBMJ (Online)
Volume334
Issue number7599
DOIs
StatePublished - Apr 28 2007

Fingerprint

Dietary Sodium
Cardiovascular Diseases
Hypertension
Sodium
Prehypertension
Counseling
Stroke
Myocardial Infarction
Outcome Assessment (Health Care)
Confidence Intervals
Blood Pressure
Morbidity
Education
Weights and Measures

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cook, N. R., Cutler, J. A., Obarzanek, E., Buring, J. E., Rexrode, K. M., Kumanyika, S. K., ... Whelton, P. K. (2007). Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the trials of hypertension prevention (TOHP). BMJ (Online), 334(7599), 885-888. https://doi.org/10.1136/bmj.39147.604896.55

Long term effects of dietary sodium reduction on cardiovascular disease outcomes : Observational follow-up of the trials of hypertension prevention (TOHP). / Cook, Nancy R.; Cutler, Jeffrey A.; Obarzanek, Eva; Buring, Julie E.; Rexrode, Kathryn M.; Kumanyika, Shiriki K.; Appel, Lawrence; Whelton, Paul K.

In: BMJ (Online), Vol. 334, No. 7599, 28.04.2007, p. 885-888.

Research output: Contribution to journalArticle

Cook, Nancy R. ; Cutler, Jeffrey A. ; Obarzanek, Eva ; Buring, Julie E. ; Rexrode, Kathryn M. ; Kumanyika, Shiriki K. ; Appel, Lawrence ; Whelton, Paul K. / Long term effects of dietary sodium reduction on cardiovascular disease outcomes : Observational follow-up of the trials of hypertension prevention (TOHP). In: BMJ (Online). 2007 ; Vol. 334, No. 7599. pp. 885-888.
@article{6bed02f395084fc2a641463ae8ff0738,
title = "Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the trials of hypertension prevention (TOHP)",
abstract = "Objective: To examine the effects of reduction in dietary sodium intake on cardiovascular events using data from two completed randomised trials, TOHP I and TOHP II. Design: Longterm follow-up assessed 10-15 years after the original trial. Setting: 10 clinic sites in 1987-90 (TOHP I) and nine sites in 1990-5 (TOHP II). Central follow-up conducted by post and phone. Participants: Adults aged 30-54 years with prehypertension. Intervention: Dietary sodium reduction, including comprehensive education and counselling on reducing intake, for 18 months (TOHP I) or 36-48 months (TOHP II). Main outcome measure: Cardiovascular disease (myocardial infarction, stroke, coronary revascularisation, or cardiovascular death). Results: 744 participants in TOHP I and 2382 in TOHP II were randomised to a sodium reduction intervention or control. Net sodium reductions in the intervention groups were 44 mmol/24 h and 33 mmol/24 h, respectively. Vital status was obtained for all participants and follow-up information on morbidity was obtained from 2415 (77{\%}), with 200 reporting a cardiovascular event. Risk of a cardiovascular event was 25{\%} lower among those in the intervention group (relative risk 0.75, 95{\%} confidence interval 0.57 to 0.99, P=0.04), adjusted for trial, clinic, age, race, and sex, and 30{\%} lower after further adjustment for baseline sodium excretion and weight (0.70, 0.53 to 0.94), with similar results in each trial. In secondary analyses, 67 participants died (0.80, 0.51 to 1.26, P=0.34). Conclusion: Sodium reduction, previously shown to lower blood pressure, may also reduce long term risk of cardiovascular events.",
author = "Cook, {Nancy R.} and Cutler, {Jeffrey A.} and Eva Obarzanek and Buring, {Julie E.} and Rexrode, {Kathryn M.} and Kumanyika, {Shiriki K.} and Lawrence Appel and Whelton, {Paul K.}",
year = "2007",
month = "4",
day = "28",
doi = "10.1136/bmj.39147.604896.55",
language = "English (US)",
volume = "334",
pages = "885--888",
journal = "British Medical Journal",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "7599",

}

TY - JOUR

T1 - Long term effects of dietary sodium reduction on cardiovascular disease outcomes

T2 - Observational follow-up of the trials of hypertension prevention (TOHP)

AU - Cook, Nancy R.

AU - Cutler, Jeffrey A.

AU - Obarzanek, Eva

AU - Buring, Julie E.

AU - Rexrode, Kathryn M.

AU - Kumanyika, Shiriki K.

AU - Appel, Lawrence

AU - Whelton, Paul K.

PY - 2007/4/28

Y1 - 2007/4/28

N2 - Objective: To examine the effects of reduction in dietary sodium intake on cardiovascular events using data from two completed randomised trials, TOHP I and TOHP II. Design: Longterm follow-up assessed 10-15 years after the original trial. Setting: 10 clinic sites in 1987-90 (TOHP I) and nine sites in 1990-5 (TOHP II). Central follow-up conducted by post and phone. Participants: Adults aged 30-54 years with prehypertension. Intervention: Dietary sodium reduction, including comprehensive education and counselling on reducing intake, for 18 months (TOHP I) or 36-48 months (TOHP II). Main outcome measure: Cardiovascular disease (myocardial infarction, stroke, coronary revascularisation, or cardiovascular death). Results: 744 participants in TOHP I and 2382 in TOHP II were randomised to a sodium reduction intervention or control. Net sodium reductions in the intervention groups were 44 mmol/24 h and 33 mmol/24 h, respectively. Vital status was obtained for all participants and follow-up information on morbidity was obtained from 2415 (77%), with 200 reporting a cardiovascular event. Risk of a cardiovascular event was 25% lower among those in the intervention group (relative risk 0.75, 95% confidence interval 0.57 to 0.99, P=0.04), adjusted for trial, clinic, age, race, and sex, and 30% lower after further adjustment for baseline sodium excretion and weight (0.70, 0.53 to 0.94), with similar results in each trial. In secondary analyses, 67 participants died (0.80, 0.51 to 1.26, P=0.34). Conclusion: Sodium reduction, previously shown to lower blood pressure, may also reduce long term risk of cardiovascular events.

AB - Objective: To examine the effects of reduction in dietary sodium intake on cardiovascular events using data from two completed randomised trials, TOHP I and TOHP II. Design: Longterm follow-up assessed 10-15 years after the original trial. Setting: 10 clinic sites in 1987-90 (TOHP I) and nine sites in 1990-5 (TOHP II). Central follow-up conducted by post and phone. Participants: Adults aged 30-54 years with prehypertension. Intervention: Dietary sodium reduction, including comprehensive education and counselling on reducing intake, for 18 months (TOHP I) or 36-48 months (TOHP II). Main outcome measure: Cardiovascular disease (myocardial infarction, stroke, coronary revascularisation, or cardiovascular death). Results: 744 participants in TOHP I and 2382 in TOHP II were randomised to a sodium reduction intervention or control. Net sodium reductions in the intervention groups were 44 mmol/24 h and 33 mmol/24 h, respectively. Vital status was obtained for all participants and follow-up information on morbidity was obtained from 2415 (77%), with 200 reporting a cardiovascular event. Risk of a cardiovascular event was 25% lower among those in the intervention group (relative risk 0.75, 95% confidence interval 0.57 to 0.99, P=0.04), adjusted for trial, clinic, age, race, and sex, and 30% lower after further adjustment for baseline sodium excretion and weight (0.70, 0.53 to 0.94), with similar results in each trial. In secondary analyses, 67 participants died (0.80, 0.51 to 1.26, P=0.34). Conclusion: Sodium reduction, previously shown to lower blood pressure, may also reduce long term risk of cardiovascular events.

UR - http://www.scopus.com/inward/record.url?scp=34247863975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247863975&partnerID=8YFLogxK

U2 - 10.1136/bmj.39147.604896.55

DO - 10.1136/bmj.39147.604896.55

M3 - Article

VL - 334

SP - 885

EP - 888

JO - British Medical Journal

JF - British Medical Journal

SN - 0959-8146

IS - 7599

ER -